- Antineoplastic Agent, Anti-PD-L1 Monoclonal Antibody
- Antineoplastic Agent, Monoclonal Antibody
Medication Safety Issues
Avelumab may be confused with atezolizumab, durvalumab, emapalumab, nivolumab.
High alert medication
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.